Lower MIAT expression conferred highly significant worse relapse-free survival (RFS) for BRCA patients, including all subtypes and also each intrinsic molecular subtype ( Figure 2 d–h).
← all excerpts
Abnormal Long Non-Coding RNAs Expression Patterns Have the Potential Ability for Predicting Survival and Treatment Response in Breast Cancer.
2
—
—
The sentences
MIAT levels showed a trend to be higher in the luminal breast cancer subtype, and KCNQ1OT1 (luminal vs.